Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Figure 6 | Journal of Orthopaedic Surgery and Research

Figure 6

From: Vascular endothelial growth factor regulates osteoblast survival – evidence for an autocrine feedback mechanism

Figure 6

The effect of exogenous VEGF 165 on primary human osteoblast BCl2 expression during spontaneous and 'pathological' apoptosis in vitro. Expression of the antiapoptotic gene BCl2 was determined using Western immunoblotting as described in Materials and Methods. Spontaneous apoptosis was measured for cells in serum free conditions. Pathological apoptosis was induced by treatment of the cultures with TNFa and anti-Fas IgM. BCl2: antiapoptotic gene, VEGF: vascular endothelial growth factor 165, TNFa: tumour necrosis factor alpha (100 ng/mL), anti-Fas IgM: anti Fas receptor immunoglobulin (1000 ng/mL). The immunoblot shown is representative in each case. Western Immunoblotting was performed for six separate experiments, with triplicates in each experiment.

Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X